• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两组各1000例儿童心脏导管插入术研究的并发症]

[Complications of two series of 1000 each heart catheterization studies in childhood].

作者信息

Beitzke A, Mache C J, Stein J I, Suppan C

机构信息

Department für Kardiologie, Universitäts-Kinderklinik, Graz.

出版信息

Wien Klin Wochenschr. 1991;103(3):75-81.

PMID:2028616
Abstract

Two series of 1,000 consecutive cardiac catheterizations in neonates, infants and older children were prospectively investigated with respect to catheter-induced complications. These were categorized into arrhythmias, vascular complications, catheter and contrast perforations, central nervous (CNS) complications, clinical deterioration and catheter-related death. Comparing series 1 and 2, the number of arrhythmias decreased from 7.6% to 5.0%, acute vascular complications decreased from 2.1% to 1.4%, the number of patients showing clinical deterioration from 2.6% to 0.6% and CNS complications from 0.4% to 0.1%, whereas catheter or contrast perforations-remained virtually constant at 0.4% and 0.5% respectively. Catheter-induced mortality decreased from 2.0% to 0.7%. The group of neonates showed the greatest reduction in serious complications and catheter-induced mortality (31.3% to 12.4% and 11.0% to 4.4%, respectively). Increasing experience of the investigators, introduction of two-dimensional echocardiography as a supplementary investigation or even catheter substitute, use of percutaneous catheterization and sheath techniques, introduction of E-type prostaglandins and increased use of intubation and anaesthesia for catheterization all played an important role in the improvement shown in this investigation. Complications are still mainly seen in the group of neonates and cyanotic patients.

摘要

对两组各1000例新生儿、婴儿及大龄儿童连续进行心脏导管插入术,并对导管相关并发症进行前瞻性研究。这些并发症分为心律失常、血管并发症、导管及造影剂穿孔、中枢神经(CNS)并发症、临床病情恶化及导管相关死亡。比较第1组和第2组,心律失常的发生率从7.6%降至5.0%,急性血管并发症从2.1%降至1.4%,临床病情恶化的患者数量从2.6%降至0.6%,CNS并发症从0.4%降至0.1%,而导管或造影剂穿孔分别维持在0.4%和0.5%基本不变。导管相关死亡率从2.0%降至0.7%。新生儿组严重并发症和导管相关死亡率降低幅度最大(分别从31.3%降至12.4%和从11.0%降至4.4%)。研究人员经验的增加、引入二维超声心动图作为辅助检查甚至导管替代手段、使用经皮导管插入术和鞘管技术、引入E型前列腺素以及增加导管插入术时插管和麻醉的使用,在本研究显示的改善中均发挥了重要作用。并发症仍主要见于新生儿组和发绀患者。

相似文献

1
[Complications of two series of 1000 each heart catheterization studies in childhood].[两组各1000例儿童心脏导管插入术研究的并发症]
Wien Klin Wochenschr. 1991;103(3):75-81.
2
Catheterization of the radial or brachial artery in neonates and infants.新生儿及婴儿桡动脉或肱动脉插管术。
Paediatr Anaesth. 2005 Aug;15(8):677-82. doi: 10.1111/j.1460-9592.2004.01522.x.
3
[The risks involved in the heart catheter examination. A retrospective evaluation of the complications after 700 examinations. IV. Vascular complications (author's transl)].心脏导管检查的相关风险。700例检查后并发症的回顾性评估。IV. 血管并发症(作者译)
Padiatr Padol. 1979;14(4):405-14.
4
[Percutaneous catheterization by means of a plastic catheter in infants and children. Experience in 104 cases].[婴儿及儿童经皮塑料导管插管术。104例经验]
Arch Inst Cardiol Mex. 1973 Nov-Dec;43(6):848-54.
5
Complications of pediatric cardiac catheterization: 18-month study.
Turk J Pediatr. 2000 Oct-Dec;42(4):294-7.
6
[Cardiac catheterization in neonates: experience in 26 neonates].[新生儿心脏导管插入术:26例新生儿的经验]
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Feb;8(1):21-3.
7
[The risks involved in the heart catheter examination. A retrospective evaluation of the complications after 700 examinations. II. Complications (author's transl)].[心脏导管检查所涉及的风险。对700例检查后并发症的回顾性评估。II. 并发症(作者译)]
Padiatr Padol. 1979;14(4):381-92.
8
[Cardiac catheterization of neonates and young infants using a flow-directed balloon catheter (author's transl)].使用血流导向球囊导管对新生儿和婴幼儿进行心导管插入术(作者译)
Herz. 1978 Apr;3(2):98-102.
9
[Current risk of heart catheterization study and angiocardiography in children. A prospective study].
Z Kardiol. 1990 May;79(5):324-35.
10
Percutaneous carciac catheterization of the neonate.
Pediatrics. 1975 May;55(5):662-5.

引用本文的文献

1
[Catheter interventions for congenital heart disease].[先天性心脏病的导管介入治疗]
Herz. 2008 Dec;33(8):592-600. doi: 10.1007/s00059-008-3133-1. Epub 2009 Jan 8.
2
The causes of Charcot-Marie-Tooth disease.夏科-马里-图思病的病因。
Cell Mol Life Sci. 2003 Dec;60(12):2547-60. doi: 10.1007/s00018-003-3133-5.
3
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.组织型纤溶酶原激活剂(阿替普酶)治疗婴幼儿和儿童心导管插入术后股动脉血栓形成
Br Heart J. 1993 Oct;70(4):382-5. doi: 10.1136/hrt.70.4.382.
4
Iopamidol in cardioangiography: a retrospective, multicentre study. Part II. Paediatric patients.碘帕醇在心血管造影中的应用:一项回顾性多中心研究。第二部分。儿科患者。
Int J Card Imaging. 1992;8(1):45-52. doi: 10.1007/BF01137565.